The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend.
10.4111/kju.2012.53.10.686
- Author:
Hyung Sang KIM
1
;
Chang Yong LEE
;
Dong Hun LIM
;
Chul Sung KIM
;
Seung BAIK
Author Information
1. Department of Urology, Chosun University School of Medicine, Gwangju, Korea. luve98@hanmail.net
- Publication Type:Original Article
- Keywords:
Biopsy;
Prostate;
Prostate-specific antigen;
Prostatic neoplasms
- MeSH:
Biopsy;
Humans;
Prostate;
Prostate-Specific Antigen;
Prostatic Neoplasms;
Reference Values
- From:Korean Journal of Urology
2012;53(10):686-690
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To identify the prostate cancer detection rate on the patients who had second prostate biopsy out of the patients who were reported negative in their first biopsy. MATERIALS AND METHODS: From July 2006 to February 2012, prostate biopsy was performed on 843 patients with over 4 ng/ml and on 618 biopsy negative patients PSA was performed from between 6 months and 9 months after biopsy. On 164 patients, second biopsy was performed, and 42 patients were selected. If there was less than 10% change between PSA before the prostate biopsy and PSA measured during 6 to 9 months after the first biopsy it was considered as no change. If above 10% increase, it was considered increase and if above 10% decrease it was considered as decrease. RESULTS: The cancer detection rate in PSA increase group was 20%, the detection rate in no change in PSA level but still over the normal range group 8.3%, and that in the PSA decrease group was 0%. When comparing prostate cancer group and non-cancer group, it is more probable to have prostate cancer when they are older, prostate volume is smaller and PSA density is higher. CONCLUSIONS: The second biopsy is strongly recommended when PSA level shows no change or increase, age is older, prostate volume is smaller or PSA density is higher.
